These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 9495845

  • 1. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
    Rady JJ, Lin W, Fujimoto JM.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):878-85. PubMed ID: 9495845
    [Abstract] [Full Text] [Related]

  • 2. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ, Holmes BB, Fujimoto JM.
    Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
    [Abstract] [Full Text] [Related]

  • 3. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
    Holmes BB, Rady JJ, Smith DJ, Fujimoto JM.
    Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
    [Abstract] [Full Text] [Related]

  • 4. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
    Rady JJ, Holmes BB, Tseng LF, Fujimoto JM.
    J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
    [Abstract] [Full Text] [Related]

  • 5. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
    Wang FS, Fujimoto JM.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
    [Abstract] [Full Text] [Related]

  • 6. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW, Kim YH, Choi YS, Song DK.
    Peptides; 1995 Jun; 16(7):1229-34. PubMed ID: 8545243
    [Abstract] [Full Text] [Related]

  • 7. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
    Fujimoto JM, Holmes B.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
    [Abstract] [Full Text] [Related]

  • 8. Elimination of the antianalgesic action of dynorphin A by spinal transsection in barbital-anesthetized mice.
    Wang FS, Rady JJ, Fujimoto JM.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):873-80. PubMed ID: 7906735
    [Abstract] [Full Text] [Related]

  • 9. Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord.
    Wu HE, Thompson J, Sun HS, Terashvili M, Tseng LF.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1101-8. PubMed ID: 15901793
    [Abstract] [Full Text] [Related]

  • 10. Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.
    Suh HW, Song DK, Kwon SH, Kim KW, Min BH, Kim YH.
    Neuropeptides; 1996 Aug; 30(4):379-84. PubMed ID: 8914865
    [Abstract] [Full Text] [Related]

  • 11. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    Izumi T.
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
    [Abstract] [Full Text] [Related]

  • 12. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 13. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice.
    Rady JJ, Fujimoto JM.
    J Pharmacol Exp Ther; 2001 Nov 21; 299(2):659-65. PubMed ID: 11602679
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
    Broberger C, Farkas-Szallasi T, Szallasi A, Lundberg JM, Hökfelt T, Wiesenfeld-Hallin Z, Xu XJ.
    Pain; 2000 Jan 21; 84(1):21-28. PubMed ID: 10601669
    [Abstract] [Full Text] [Related]

  • 20. Enterostatin (APGPR) suppresses the analgesic activity of morphine by a CCK-dependent mechanism.
    Takenaka Y, Shimano T, Yamada Y, Yoshida M, Ohinata K, Yoshikawa M.
    Peptides; 2008 Apr 21; 29(4):559-63. PubMed ID: 18304696
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.